Form D · Biotechnology
Orion Biotechnology Canada Ltd.
Ottawa, Ontario, Z4 · CIK 0001827388
Offering snapshot reported Aug 26, 2025 · SEC filing
- Reported sold
- $6.81M Offering amount: $15M
- Investors reported
- 34 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jul 8, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 26, 2025 | Amendment | $6,809,726 | No comparison | 34 | SEC filing |
| Jul 23, 2024 | Initial | $743,385 | No comparison | 5 | SEC filing |
| Mar 15, 2023 | Amendment | $9,889,371 | $4,452,074vs Jun 22, 2021 | 114 | SEC filing |
| Jun 22, 2021 | Amendment | $5,437,297 | No comparison | Not reported | SEC filing |
| Jun 15, 2021 | Initial | $5,437,297 | No comparison | Not reported | SEC filing |
| Oct 9, 2020 | Initial | $605,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-519487
Source: Form D, filed Aug 26, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rudolf Bom | Director |
| Jason Burke | Executive |
| Lonnel Coats | Director |
| Theresa Firestone | Director |
| Jean Forcione | Director |
| Mark Groper | Director |
| Thomas Hecht | Director |
| Mark Hecht | Director |
| Katie Hewitt | Director |
| John Jussup | Executive |
| Anatolii Klepatsky | Director, Executive |
| Anatole Klepatsky | Director, Executive |
| Anatolii Klepatskyi | Director |
| Dmytro Martynenko | Director |
| Bradford Smith | Director |
| Praveen Tyle | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
343 Preston Street, 11 Th Floor
Ottawa, Ontario, Z4, K1S1N4
Ottawa, Ontario, Z4, K1S1N4